🎁 'Tis the season to support public service journalism Donate Now

GlaxoSmithKline CEO on why drugs cost so much

May 10, 2016
Sir Andrew Witty says that there's frankly not enough transparency when it comes to drug prices in the U.S.
Sir Andrew Witty became CEO of GlaxoSmithKline in 2008.
Courtesy of gsk.com